Target intelligence / Profile preview

Mycobacterial ATP synthase subunit epsilon (AtpC) (AtpC)

Target
AtpC
Molecular classification
Enzyme, ATP synthase complex subunit
01

Overview

The Mycobacterial ATP synthase subunit epsilon, encoded by the atpC gene, is a vital component of the F1 sector of the F1Fo-ATP synthase complex (UniProt: P9WPU1). This enzyme is responsible for synthesizing ATP from ADP and inorganic phosphate, driven by the proton motive force across the bacterial membrane (PubMed: 21613214). In Mycobacterium tuberculosis, the epsilon subunit is unique because it contains a C-terminal extension that acts as an intrinsic inhibitor of ATP hydrolysis (PubMed: 24561181). This prevents the bacterium from depleting its ATP stores during periods of low metabolic activity or hypoxia, such as during latent infection (PubMed: 32665413). This regulatory function makes the epsilon subunit an attractive target for the development of new antibiotics against tuberculosis. While the approved drug Bedaquiline targets the c-subunit of the same complex, the epsilon subunit provides a distinct site for therapeutic intervention. Inhibiting this subunit can disrupt the coupling between the proton-pumping Fo sector and the catalytic F1 sector. This disruption leads to a lethal drop in cellular energy levels and inhibits the growth of both active and dormant mycobacteria. Research into small molecules and peptides that bind this subunit is ongoing to overcome drug resistance in tuberculosis treatment.

Other names
ATP synthase F1 sector subunit epsilonF-type ATPase subunit epsilonAtpCATP synthase epsilon chainMycobacterium tuberculosis ATP synthase epsilon subunit
02

Mechanism of action

Inhibition of the ATP synthase complex through allosteric modulation or physical obstruction of the epsilon subunit's regulatory movement, thereby preventing ATP synthesis and/or uncontrolled ATP hydrolysis (PubMed: 21613214, 32665413).

03

Biological functions

ATP synthesisRegulation of ATPase activityOxidative phosphorylationEnergy homeostasis
04

Disease associations

Infection
05

Safety considerations

Selectivity against human mitochondrial ATP synthasePotential for off-target effects on host energy metabolismDevelopment of resistance through atpC mutations
06

Interacting drugs

Bedaquiline (targets the c-subunit of the same complex)

2 more in the full profile.

07

Biomarkers

Intracellular ATP levelsMycobacterial viabilitySputum culture conversion

Beyond the preview

Go deeper on Mycobacterial ATP synthase subunit epsilon (AtpC) (AtpC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterial ATP synthase subunit epsilon (AtpC) (AtpC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call